Profil
Christian Cortis held several positions throughout his career.
He worked as the Director of Business Development at Gemin X Pharmaceuticals US, Inc. from 2002 to 2006.
He also served as a Director at PRCL Research Inc. Additionally, he was the Director at OpenEye Scientific Software, Inc. from 2015 to 2022.
Dr. Cortis was the Head of Business Development at Synta Pharmaceuticals Corp.
and the Vice President of Product Development at Astria Therapeutics, Inc. in 2010.
He worked as an Associate at Booz Allen Hamilton, Inc. from 1998 to 2000.
Dr. Cortis held the position of Principal at ATV Capital Management Inc. He was the Chief Operating Officer at AVROBIO, Inc. and the Chief Operating & Financial Officer at Tectonic Operating Co., Inc. In 2024, he became the Chief Operating Officer & Head-Investors at Tectonic Therapeutic, Inc. From 2015 to 2019, he served as the Chief Financial Officer & Head-Finance at Agenus, Inc. Dr. Cortis obtained a doctorate degree from The Trustees of Columbia University in The City of New York in 1996.
He also completed his undergraduate studies at McGill University.
Ehemalige bekannte Positionen von Christian Cortis
| Unternehmen | Position | Ende |
|---|---|---|
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Finanzdirektor/CFO | 03.06.2024 |
OpenEye Scientific Software, Inc.
OpenEye Scientific Software, Inc. Packaged SoftwareTechnology Services Develops molecular modeling and simulation software | Direktor/Vorstandsmitglied | 01.08.2022 |
| AGENUS INC. | Finanzdirektor/CFO | 14.08.2019 |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Corporate Officer/Principal | 01.05.2006 |
Ausbildung von Christian Cortis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATV Capital Management Inc.
ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management invests in private companies located in the United States. The firm focuses on information technology, healthcare, and cleantech. It participates in early stage transactions. | Finance |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Packaged SoftwareTechnology Services Builds advanced technology to fast-track results for government—boosting efficiencies, saving money and safeguarding | Technology Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
OpenEye Scientific Software, Inc.
OpenEye Scientific Software, Inc. Packaged SoftwareTechnology Services Develops molecular modeling and simulation software | Technology Services |
PRCL Research Inc.
PRCL Research Inc. Medical/Nursing ServicesHealth Services Develops and proofs a compound for the treatment of chronic inflammatory diseases | Health Services |
AVROBIO, Inc.
AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
















